Alkyl Amines Chemicals Balance Sheet Health
Financial Health criteria checks 6/6
Alkyl Amines Chemicals has a total shareholder equity of ₹13.1B and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹17.1B and ₹3.9B respectively. Alkyl Amines Chemicals's EBIT is ₹2.2B making its interest coverage ratio 201.8. It has cash and short-term investments of ₹1.3B.
Key information
0%
Debt to equity ratio
₹0
Debt
| Interest coverage ratio | 201.8x |
| Cash | ₹1.34b |
| Equity | ₹13.12b |
| Total liabilities | ₹3.93b |
| Total assets | ₹17.05b |
Recent financial health updates
These 4 Measures Indicate That Alkyl Amines Chemicals (NSE:ALKYLAMINE) Is Using Debt Extensively
Dec 27
Is Alkyl Amines Chemicals (NSE:ALKYLAMINE) Using Too Much Debt?
Aug 30Here's Why Alkyl Amines Chemicals (NSE:ALKYLAMINE) Can Manage Its Debt Responsibly
Mar 15These 4 Measures Indicate That Alkyl Amines Chemicals (NSE:ALKYLAMINE) Is Using Debt Reasonably Well
Aug 24We Think Alkyl Amines Chemicals (NSE:ALKYLAMINE) Can Manage Its Debt With Ease
Nov 07Recent updates
Alkyl Amines Chemicals Limited's (NSE:ALKYLAMINE) Price In Tune With Earnings
Nov 05Alkyl Amines Chemicals (NSE:ALKYLAMINE) Could Be Struggling To Allocate Capital
Aug 28Alkyl Amines Chemicals Limited's (NSE:ALKYLAMINE) Share Price Not Quite Adding Up
Aug 01Should Shareholders Reconsider Alkyl Amines Chemicals Limited's (NSE:ALKYLAMINE) CEO Compensation Package?
Jun 26Investors Could Be Concerned With Alkyl Amines Chemicals' (NSE:ALKYLAMINE) Returns On Capital
Mar 13These 4 Measures Indicate That Alkyl Amines Chemicals (NSE:ALKYLAMINE) Is Using Debt Extensively
Dec 27Is Alkyl Amines Chemicals (NSE:ALKYLAMINE) Using Too Much Debt?
Aug 30Why You Should Care About Alkyl Amines Chemicals' (NSE:ALKYLAMINE) Strong Returns On Capital
Jul 01A Look Into Alkyl Amines Chemicals' (NSE:ALKYLAMINE) Impressive Returns On Capital
Mar 30Here's Why Alkyl Amines Chemicals (NSE:ALKYLAMINE) Can Manage Its Debt Responsibly
Mar 15Alkyl Amines Chemicals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 13When Should You Buy Alkyl Amines Chemicals Limited (NSE:ALKYLAMINE)?
Jan 24Alkyl Amines Chemicals (NSE:ALKYLAMINE) Knows How To Allocate Capital
Sep 29These 4 Measures Indicate That Alkyl Amines Chemicals (NSE:ALKYLAMINE) Is Using Debt Reasonably Well
Aug 24Is There Now An Opportunity In Alkyl Amines Chemicals Limited (NSE:ALKYLAMINE)?
Aug 09Alkyl Amines Chemicals (NSE:ALKYLAMINE) Is Increasing Its Dividend To ₹10.00
Jul 10Alkyl Amines Chemicals' (NSE:ALKYLAMINE) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 26Why The 38% Return On Capital At Alkyl Amines Chemicals (NSE:ALKYLAMINE) Should Have Your Attention
Jun 07Here's Why I Think Alkyl Amines Chemicals (NSE:ALKYLAMINE) Might Deserve Your Attention Today
May 06Is There Now An Opportunity In Alkyl Amines Chemicals Limited (NSE:ALKYLAMINE)?
Mar 30Under The Bonnet, Alkyl Amines Chemicals' (NSE:ALKYLAMINE) Returns Look Impressive
Feb 03Is Now The Time To Look At Buying Alkyl Amines Chemicals Limited (NSE:ALKYLAMINE)?
Dec 01Alkyl Amines Chemicals' (NSE:ALKYLAMINE) Profits Appear To Have Quality Issues
Nov 09We Think Alkyl Amines Chemicals (NSE:ALKYLAMINE) Can Manage Its Debt With Ease
Nov 07Here's Why We Think Alkyl Amines Chemicals (NSE:ALKYLAMINE) Is Well Worth Watching
Sep 16Why The 46% Return On Capital At Alkyl Amines Chemicals (NSE:ALKYLAMINE) Should Have Your Attention
Jul 13Financial Position Analysis
Short Term Liabilities: ALKYLAMINE's short term assets (₹5.5B) exceed its short term liabilities (₹2.6B).
Long Term Liabilities: ALKYLAMINE's short term assets (₹5.5B) exceed its long term liabilities (₹1.4B).
Debt to Equity History and Analysis
Debt Level: ALKYLAMINE is debt free.
Reducing Debt: ALKYLAMINE has no debt compared to 5 years ago when its debt to equity ratio was 18.9%.
Debt Coverage: ALKYLAMINE has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: ALKYLAMINE has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 23:13 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Alkyl Amines Chemicals Limited is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nitin Bhasin | Ambit Capital |
| Karan Khanna | Ambit Capital |
| Kameswari V. S. Chavali | FirstCall Research |